TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Tonix Pharmaceuticals Holding Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$5.73−0.31 (-5.13%)
Close on Oct 19, 2026
- Market cap
- $95.32M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 18, 2025(first seen in filings) | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Feb 5, 2025 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Jun 10, 2024 | 1-for-32 reverse | Earlier per-share figures multiplied by 32 |
| Aug 8, 2022(first seen in filings) | 1-for-31.5 reverse | Earlier per-share figures multiplied by 31.5 |
| May 17, 2022 | 1-for-32 reverse | Earlier per-share figures multiplied by 32 |
| Nov 1, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Dec 31, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Nov 28, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 13, 2017(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Mar 17, 2017 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 7, 2013(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 1, 2013 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |